Updates are available Correction dated 2023-12-13
Click to view Correction: https://doi.org/10.1186/s13073-023-01251-x
-
Authors
Hubbard, Erika L. https://orcid.org/0000-0002-7972-2879
Bachali, Prathyusha
Kingsmore, Kathryn M.
He, Yisha
Catalina, Michelle D.
Grammer, Amrie C.
Lipsky, Peter E.
-
Funding
Funding for this research was provided by:
RILITE Foundation
- License Information
-
More Information
Article History
Received: 9 March 2023
Accepted: 25 September 2023
First Online: 16 October 2023
Change Date: 13 December 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s13073-023-01251-x
Declarations
:
: All data utilized in this study has been previously published and is publicly available, except for the full clinical metadata of GSE88884. Approval for publication of these data has been provided by Eli Lilly & Co. and has been previously reported []. The research performed in the Lilly studies was in compliance with the Helsinki Declaration.
: Not applicable.
: All authors are or were salaried employees of AMPEL BioSolutions, LLC at the time of contribution to the manuscript.
